MedTrace Logo

Relation Between Bone Mineral Density, Gross Motor Function and Quality of Life In Children With Cerebral Palsy

NCT06180395 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2024-03-06

No results posted yet for this study

Summary

studying the relationship between Bone Mineral Density, Gross Motor Function and, Quality of Life with CP can provide valuable insights into the musculoskeletal consequences of motor impairments and guide interventions to improve bone health.

Statement of the problem Is there a relation between Bone Mineral Density, Gross Motor Function and Quality of Life in children with CP ? Purpose of the study

To study the relationship between:

1. Bone Mineral Density and Gross Motor Function in ambulant and non-ambulant CP children.
2. Bone Mineral Density and Quality of Life in ambulant and non-ambulant CP children.
3. Gross Motor Function and Quality of Life in ambulant and non-ambulant CP children.

Conditions

  • Cerebral Palsy
  • Bone Density, Low
  • Gross Motor Development Delay

Interventions

OTHER

Group 1

consisted of 37 children with CP classified to level I, II and III according to GMFCS., then: Dual-energy X-ray absorptiometry (DXA) scans will be used to assess bone mineral density (BMD). Gross motor function measurement scale (GMFM) will be used to assess gross motor function. Quality of Life Questionnaire for Children (CP QOL-Child) will be used to assess quality of life (QOL).

OTHER

Group 2

consisted of 38 children with CP classified to level IV and V according to GMFCS. then: Dual-energy X-ray absorptiometry (DXA) scans will be used to assess bone mineral density (BMD). Gross motor function measurement scale (GMFM) will be used to assess gross motor function. Quality of Life Questionnaire for Children (CP QOL-Child) will be used to assess quality of life (QOL).

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Elham Elsayed Salem, professor · Cairo University

Eligibility

Min Age
7 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-10
Primary Completion
2024-03-31
Completion
2024-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06180395 on ClinicalTrials.gov